Skip to main content

​​​NATRILIX SR indapamide 1.5mg prolonged-release film-coated tablets (Ireland)​​ 

Section 19A approved medicine
​​​NATRILIX SR indapamide 1.5mg prolonged-release film-coated tablets (Ireland)​​ 
Section 19A approval holder
​Servier Laboratories (Aust.) Pty Ltd ABN 54 004 838 500
Phone
613 8823 7333
Approved until
Status
Current
Medicines in short supply/unavailable
APO-INDAPAMIDE SR indapamide hemihydrate 1.5 mg modified release tablet blister pack - ARTG 208007
Indication(s)

Treatment of hypertension. It may be tried as a sole therapeutic agent in the treatment of hypertension. Normally, indapamide is used as the initial agent in multiple drug regimes.

Images
Picture of ​​​NATRILIX SR indapamide 1.5mg prolonged-release film-coated tablets - carton